Patents Assigned to Canthera Therapeutics Inc.
  • Publication number: 20130203757
    Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
    Type: Application
    Filed: November 16, 2012
    Publication date: August 8, 2013
    Applicants: THE GENERAL HOSPITAL CORPORATION, CANTHERA THERAPEUTICS INC.
    Inventors: Canthera Therapeutics Inc., The General Hospital Corporation
  • Patent number: 8318737
    Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: November 27, 2012
    Assignees: Canthera Therapeutics Inc., The General Hospital Corporation
    Inventors: Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova, Sam Lee
  • Publication number: 20120157455
    Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
    Type: Application
    Filed: June 17, 2011
    Publication date: June 21, 2012
    Applicant: CANTHERA THERAPEUTICS, INC.
    Inventors: Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova, Sam Lee
  • Publication number: 20120059004
    Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
    Type: Application
    Filed: February 16, 2011
    Publication date: March 8, 2012
    Applicant: CANTHERA THERAPEUTICS, INC.
    Inventors: PETER ELLIOTT, ANNA MANDINOVA, MICHAEL ANDREW FOLEY, ROBERT GOULD, SAM LEE
  • Publication number: 20110053938
    Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
    Type: Application
    Filed: September 2, 2010
    Publication date: March 3, 2011
    Applicant: CANTHERA THERAPEUTICS, INC.
    Inventors: Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova, Sam Lee